Loading clinical trials...
Loading clinical trials...
Nonalcoholic fatty liver disease (NAFLD), fatty infiltration of the liver in the absence of alcohol use, is an increasingly recognized complication of obesity, with prevalence estimates of about 30% o...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
NCT07278128 · Polycystic Ovary Syndrome (PCOS) With Concurrent Nonalcoholic Fatty Liver Disease (NAFLD)
NCT04371653 · Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus
NCT03836443 · Nonalcoholic Fatty Liver Disease (NAFLD)
NCT03486912 · Hepatic Cirrhosis, Liver Fibrosis, and more
NCT03486899 · Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD), and more
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions